Ceribell, INC S-1 registration statements

CeriBell, a medical technology company focused on neurological diagnostics, is set to launch its initial public offering, offering 10,606,060 shares with an expected price range of $16.00 to $17.00 per share.

Ceribell, Inc. introduces its 2024 Incentive Award Plan to attract, retain, and motivate key personnel through equity ownership opportunities.

CeriBell, Inc. has filed an amended S-1 registration statement detailing its corporate governance structure, bylaws, and other key information in preparation for its initial public offering.

Ceribell, a medical technology company, files an S-1 registration statement for an IPO to further its point-of-care EEG platform in acute care settings.